Hydronidone
- Generic Name
- Hydronidone
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C12H11NO2
- CAS Number
- 851518-71-3
- Unique Ingredient Identifier
- RXQ128313W
- Background
Hydronidone has antifibrotic activity.
- Indication
Investigated for use/treatment in liver disease.
- Associated Conditions
- -
- Associated Therapies
- -
Study on Pharmacokinetics of Hydronidone
- First Posted Date
- 2019-11-14
- Last Posted Date
- 2021-03-24
- Lead Sponsor
- Beijing Continent Pharmaceutical Co, Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT04162821
- Locations
- 🇨🇳
Ethics committee of drug clinical trials of huazhong university of science and technology, Wuhan, Hubei, China
Study on PK of Hydronidone in Patients and Special Population
- First Posted Date
- 2019-10-11
- Last Posted Date
- 2021-03-24
- Lead Sponsor
- Beijing Continent Pharmaceutical Co, Ltd.
- Target Recruit Count
- 8
- Registration Number
- NCT04123769
- Locations
- 🇨🇳
Medical ethics committee of wuhan infectious disease hospital, Wuhan, Hubei, China
A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic Hepatitis
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-07-16
- Last Posted Date
- 2022-06-23
- Lead Sponsor
- Shanghai Genomics, Inc.
- Target Recruit Count
- 168
- Registration Number
- NCT02499562
- Locations
- 🇨🇳
Shanghai General Hospital, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath